Specimen Collection Cards Market to Reach USD 1.42 Billion by 2034 Driven

Pune, India - December 2025 - The global Specimen Collection Cards Market, valued at USD 0.82 billion in 2024, is projected to reach USD 1.42 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Increasing demand for dried blood spot (DBS) cards, remote sample collection, and expanding use in newborn screening and genetic testing are fueling market growth.

Market Summary
The Specimen Collection Cards Market is growing steadily as healthcare providers, diagnostic laboratories, and research organizations adopt DBS and other dried sample collection cards for efficient, low-cost, and stable sample transportation.

These cards simplify the collection of blood, saliva, buccal cells, and other biological samples, eliminating the need for cold chains and enabling remote diagnostics. Their use is rising in newborn screening programs, infectious disease testing, toxicology, pharmacokinetics, genomics, forensics, and population health studies. The expansion of at-home testing kits, decentralized clinical trials, and large-scale biobanking initiatives is further boosting demand. North America leads the market, while Asia-Pacific is the fastest-growing region as governments expand newborn screening coverage.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73187

Key Takeaways
• 2024 Market Size: USD 0.82 Billion
• 2034 Forecast: USD 1.42 Billion
• CAGR: 5.4% (2025-2034)
• Dried blood spot (DBS) cards dominating global usage
• Strong adoption in forensics, toxicology & genetic screening
• Remote and at-home sample collection driving new opportunities

Market Drivers
• Expansion of newborn screening programs globally
• Growth in decentralized clinical trials (DCTs)
• Rising demand for remote & at-home diagnostics
• Increased forensic testing and population health surveillance
• Cost-effective transport & storage without refrigeration
Explore Full Report here:
https://exactitudeconsultancy.com/reports/73187/specimen-collection-cards-market

Segmentation Snapshot
By Product Type
• Dried Blood Spot (DBS) Cards
• Saliva Collection Cards
• Buccal Swab Collection Cards
• Multipurpose Biological Specimen Cards

By Application
• Newborn Screening
• Infectious Disease Diagnostics
• Genomics & Genetic Testing
• Toxicology & Forensics
• Clinical Trials
• Pharmacokinetic Studies
• Others

By End User
• Hospitals & Clinics
• Diagnostic Laboratories
• Forensic Labs
• Research Institutes
• Home Testing Providers

By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73187

Recent Developments
• New high-capacity DBS cards introduced for genetic and metabolic testing.
• Growing adoption of specimen cards in decentralized clinical trial kits.
• Forensic laboratories integrating advanced specimen card tracking systems.

Expert Quote - Irfan Tamboli, Business Development Executive
"Specimen collection cards are transforming diagnostics by enabling stable, low-cost, and remote biological sample collection. Their expanding role in newborn screening and genomics is driving strong market momentum."

Conclusion
The Specimen Collection Cards Market will continue to grow through 2034 as remote diagnostics, DCTs, forensic testing, and large-scale health screening programs expand globally. Companies developing improved card chemistries, automation-friendly formats, and integrated digital tracking systems will lead the next wave of market growth.

This report is also available in the following languages : Japanese (標本収集カード市場), Korean (표본 수집 카드 시장), Chinese (标本采集卡市场), French (Marché des cartes de collection d'échantillons), German (Markt für Musterkarten), and Italian (Mercato delle schede di raccolta campioni), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73187

Our More Reports:

Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market
https://exactitudeconsultancy.com/reports/72065/nucleic-acid-and-gene-therapies-in-neuromuscular-disorders-market

Partial Epilepsy Market
https://exactitudeconsultancy.com/reports/72067/partial-epilepsy-market

Partial Seizure Market
https://exactitudeconsultancy.com/reports/72069/partial-seizure-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.